Endovascular Treatment of Iliac Occlusive Disease:
Use of endovascular interventions for arterial occlusive lesions continues to increase. With the evolution of the technology supporting these therapeutic measures, the results of these interventions continue to improve. In general, a comparison of techniques for revascularization of iliac occlusive diseases shows similar initial technical success rates for open versus percutaneous transluminal angioplasty. Angioplasty is often associated with lower periprocedural morbidity and mortality rates. Conversely, surgery frequently provides greater long-term patency, although late failure of percutaneous therapies may occur but still can be treated successfully with reintervention. The perpetual buildup of experience with angioplasty and stenting will eventually characterize its role in the management of occlusive disease. This review outlines the current consensus and applicability of endovascular management of iliac occlusive diseases.
In this era of "endovascular revolution," it is crucial for a vascular surgeon to keep apprised of the latest surgical approaches to treating iliac artery occlusive diseases, bearing in mind that treatment should be tailored for every patient according to an individual's morphology and comorbidity. This review article is designed to highlight the most recent philosophies in the management of iliac occlusive diseases.
Abstract and Introduction
Abstract
Use of endovascular interventions for arterial occlusive lesions continues to increase. With the evolution of the technology supporting these therapeutic measures, the results of these interventions continue to improve. In general, a comparison of techniques for revascularization of iliac occlusive diseases shows similar initial technical success rates for open versus percutaneous transluminal angioplasty. Angioplasty is often associated with lower periprocedural morbidity and mortality rates. Conversely, surgery frequently provides greater long-term patency, although late failure of percutaneous therapies may occur but still can be treated successfully with reintervention. The perpetual buildup of experience with angioplasty and stenting will eventually characterize its role in the management of occlusive disease. This review outlines the current consensus and applicability of endovascular management of iliac occlusive diseases.
Introduction
In this era of "endovascular revolution," it is crucial for a vascular surgeon to keep apprised of the latest surgical approaches to treating iliac artery occlusive diseases, bearing in mind that treatment should be tailored for every patient according to an individual's morphology and comorbidity. This review article is designed to highlight the most recent philosophies in the management of iliac occlusive diseases.